1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Global Active Pharmaceutical Ingredients (API) Market Analysis & Trends - Industry Forecast to 2020

The Global Active Pharmaceutical Ingredients (API) Market is poised to grow at a CAGR of around 6.9% in the next 5 years to reach approximately $175 billion by 2020.

This industry report analyzes the global markets for Active Pharmaceutical Ingredients (API) across all the given segments in the research scope. It presents historical market data for 2012, 2013, 2014 revenue estimations are presented for 2015 and forecasts till 2020. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report provides comprehensive market analysis across four major geographies such as North America, Europe, Asia Pacific and Other parts of the world.

The study presents detailed market analysis with inputs derived from industry professionals. A special focus has been made on 17 countries such as U.S., Canada, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary research and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

The Active Pharmaceutical Ingredients (API) Market report provides 252 data tables, includes charts and graphs for visual analysis.

Regional Analysis:
North America
- US
- Canada
- Mexico

Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe

Asia Pacific
- China
- Japan
- India
- Australia
- New Zealand
- Rest of Asia

Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt

Report Highlights:
- The report provides a detailed analysis with current and future market trends to identify the investment opportunities
- Market forecasts till 2020, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and countries
- Key developments and strategies observed in the market
- In-depth company profiles of key players and upcoming prominent players
- Market opportunities and recommendations for new investments

Table Of Contents

Global Active Pharmaceutical Ingredients (API) Market Analysis and Trends - Industry Forecast to 2020
1 Market Outline
1.1 Market Trends
1.2 Regulatory Factors
1.3 Application Analysis
1.4 Strategic Benchmarking
1.5 Opportunity Analysis

2 Executive Summary

3 Market Overview
3.1 Current Trends
3.1.1 RandD work in the development of biotech HPAPI's is gaining pace
3.1.2 Recent Technological Developments in Global Active Pharmaceutical Ingredients maket
3.1.3 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry

4 Global Active Pharmaceutical Ingredients market by Therapeutic applications
4.1 Anti-Infectives
4.1.1 Anti-Infectives Market Forecast to 2020
4.2 Cardiovascular and hematopoietic system
4.2.1 Cardiovascular and hematopoietic system Market Forecast to 2020
4.3 Diabetes
4.3.1 Diabetes Market Forecast to 2020
4.4 Endocrinology
4.4.1 Endocrinology Market Forecast to 2020
4.5 Gastrointestinal disorder
4.5.1 Gastrointestinal disorder Market Forecast to 2020
4.6 Hormonal-related disorder
4.6.1 Hormonal-related disorder Market Forecast to 2020
4.7 Metabolic disorder
4.7.1 Metabolic disorder Market Forecast to 2020
4.8 Musculo-skeletal disorder
4.8.1 Musculo-skeletal disorder Market Forecast to 2020
4.9 Nephrology
4.9.1 Nephrology Market Forecast to 2020
4.10 Neurological Disorders
4.10.1 Neurological Disorders Market Forecast to 2020
4.11 Obesity
4.11.1 Obesity Market Forecast to 2020
4.12 Oncology
4.12.1 Oncology Market Forecast to 2020
4.13 Ophthalmology
4.13.1 Ophthalmology Market Forecast to 2020
4.14 Orthopedic Disorders
4.14.1 Orthopedic Disorders Market Forecast to 2020
4.15 Pulmonology
4.15.1 Pulmonology Market Forecast to 2020
4.16 Respiratory System
4.16.1 Respiratory System Market Forecast to 2020
4.17 Others
4.17.1 Others
4.17.1.1 ENT
4.17.1.1.1 ENT Market Forecast to 2020
4.17.2.2 Anesthesia
4.17.2.1.1 Anesthesia Market Forecast to 2020
4.17.3.3 Eye
4.17.3.1.1 Eye Market Forecast to 2020

5 Global Active Pharmaceutical Ingredients market by type of API
5.1 Biotech API
5.1.1 Biotech API Market Forecast to 2020
5.1.1.1 Recombinant Proteins
5.1.1.1.1 Recombinant Proteins Market Forecast to 2020
5.1.1.2 Monoclonal Antibodies
5.1.1.2.1 Monoclonal Antibodies Market Forecast to 2020
5.1.1.3 Vaccines
5.1.1.3.1 Vaccines Market Forecast to 2020
5.2 Synthetic chemical API
5.2.1 Synthetic chemical API Market Forecast to 2020
5.2.1.1 Generic Synthetic API
5.2.1.1.1 Generic Synthetic API Market Forecast to 2020
5.2.2.1 Innovative Synthetic API
5.2.2.1.1 Innovative Synthetic API Market Forecast to 2020

6 Global Active Pharmaceutical Ingredients market by type of manufacturing
6.1 API contract manufacturing
6.1.1 API contract manufacturing Market Forecast to 2020
6.2 Captive API Manufacturers
6.2.1 Captive API Manufacturering Market Forecast to 2020

7 Global Active Pharmaceutical Ingredients market by Type of Drug
7.1 Generic Prescription Drugs
7.1.1 Generic Prescription Drugs Market Forecast to 2020
7.2 Over-the-counter Drugs
7.2.1 Over-the-counter Drugs Market Forecast to 2020
7.3 Branded Prescription Drugs
7.3.1 Branded Prescription Drugs Market Forecast to 2020

8 Global Active Pharmaceutical Ingredients market by Geography
8.1 North America
8.2 Europe
8.3 Asia Pacific
8.4 Middle East
8.5 Latin America
8.8 Rest of the World (RoW)

9 Leading Companies
9.1 Aurobindo Pharma Ltd.
9.2 Bayer Healthcare (Germany)
9.3 Bioniche Animal Health (Canada)
9.4 Boehringer Ingelheim (Germany)
9.5 Ceva Animal Health, Inc.
9.6 Dr. Reddy's Laboratories Ltd.
9.7 Elanco Animal Health (U.S.)
9.8 Heska Co. (U.S.)
9.9 Merck Animal Health (U.S.)
9.10 Merial Inc. (Sanofi) (France)
9.11 Mylan Inc.
9.12 Sigma-Aldrich Corporation
9.13 Sun Pharmaceutical Industries Ltd.
9.14 Virbac
9.15 Zoetis (U.S.)

List of Tables
Table 1 Active Pharmaceutical Ingredients market by Therapeutic applications Global Market Forecast (2015-2020) ($MN)
Table 2 Anti-Infectives Global Market Forecast (2015-2020) ($MN)
Table 3 Cardiovascular and hematopoietic system Global Market Forecast (2015-2020) ($MN)
Table 4 Diabetes Global Market Forecast (2015-2020) ($MN)
Table 5 Endocrinology Global Market Forecast (2015-2020) ($MN)
Table 6 Gastrointestinal disorder Global Market Forecast (2015-2020) ($MN)
Table 7 Hormonal-related disorder Global Market Forecast (2015-2020) ($MN)
Table 8 Metabolic disorder Global Market Forecast (2015-2020) ($MN)
Table 9 Musculo-skeletal disorder Global Market Forecast (2015-2020) ($MN)
Table 10 Nephrology Global Market Forecast (2015-2020) ($MN)
Table 11 Neurological Disorders Global Market Forecast (2015-2020) ($MN)
Table 12 Obesity Global Market Forecast (2015-2020) ($MN)
Table 13 Oncology Global Market Forecast (2015-2020) ($MN)
Table 14 Ophthalmology Global Market Forecast (2015-2020) ($MN)
Table 15 Orthopedic Disorders Global Market Forecast (2015-2020) ($MN)
Table 16 Pulmonology Global Market Forecast (2015-2020) ($MN)
Table 17 Respiratory System Global Market Forecast (2015-2020) ($MN)
Table 18 Others Global Market Forecast (2015-2020) ($MN)
Table 19 ENT Global Market Forecast (2015-2020) ($MN)
Table 20 Anesthesia Global Market Forecast (2015-2020) ($MN)
Table 21 Eye Global Market Forecast (2015-2020) ($MN)
Table 22 Active Pharmaceutical Ingredients market by type of API Global Market Forecast (2015-2020) ($MN)
Table 23 Biotech API Global Market Forecast (2015-2020) ($MN)
Table 24 Recombinant Proteins Global Market Forecast (2015-2020) ($MN)
Table 25 Monoclonal Antibodies Global Market Forecast (2015-2020) ($MN)
Table 26 Vaccines Global Market Forecast (2015-2020) ($MN)
Table 27 Synthetic chemical API Global Market Forecast (2015-2020) ($MN)
Table 28 Generic Synthetic API Global Market Forecast (2015-2020) ($MN)
Table 29 Innovative Synthetic API Global Market Forecast (2015-2020) ($MN)
Table 30 Active Pharmaceutical Ingredients market by type of manufacturing Global Market Forecast (2015-2020) ($MN)
Table 31 API contract manufacturing Global Market Forecast (2015-2020) ($MN)
Table 32 Captive API Manufacturers Global Market Forecast (2015-2020) ($MN)
Table 33 Active Pharmaceutical Ingredients market by Type of Drug Global Market Forecast (2015-2020) ($MN)
Table 34 Generic Prescription Drugs Global Market Forecast (2015-2020) ($MN)
Table 35 Over-the-counter Drugs Global Market Forecast (2015-2020) ($MN)
Table 36 Branded Prescription Drugs Global Market Forecast (2015-2020) ($MN)
Table 37 Active Pharmaceutical Ingredients market by Therapeutic applications North America Market Forecast (2015-2020) ($MN)
Table 38 Anti-Infectives North America Market Forecast (2015-2020) ($MN)
Table 39 Cardiovascular and hematopoietic system North America Market Forecast (2015-2020) ($MN)
Table 40 Diabetes North America Market Forecast (2015-2020) ($MN)
Table 41 Endocrinology North America Market Forecast (2015-2020) ($MN)
Table 42 Gastrointestinal disorder North America Market Forecast (2015-2020) ($MN)
Table 43 Hormonal-related disorder North America Market Forecast (2015-2020) ($MN)
Table 44 Metabolic disorder North America Market Forecast (2015-2020) ($MN)
Table 45 Musculo-skeletal disorder North America Market Forecast (2015-2020) ($MN)
Table 46 Nephrology North America Market Forecast (2015-2020) ($MN)
Table 47 Neurological Disorders North America Market Forecast (2015-2020) ($MN)
Table 48 Obesity North America Market Forecast (2015-2020) ($MN)
Table 49 Oncology North America Market Forecast (2015-2020) ($MN)
Table 50 Ophthalmology North America Market Forecast (2015-2020) ($MN)
Table 51 Orthopedic Disorders North America Market Forecast (2015-2020) ($MN)
Table 52 Pulmonology North America Market Forecast (2015-2020) ($MN)
Table 53 Respiratory System North America Market Forecast (2015-2020) ($MN)
Table 54 Others North America Market Forecast (2015-2020) ($MN)
Table 55 ENT North America Market Forecast (2015-2020) ($MN)
Table 56 Anesthesia North America Market Forecast (2015-2020) ($MN)
Table 57 Eye North America Market Forecast (2015-2020) ($MN)
Table 58 Active Pharmaceutical Ingredients market by type of API North America Market Forecast (2015-2020) ($MN)
Table 59 Biotech API North America Market Forecast (2015-2020) ($MN)
Table 60 Recombinant Proteins North America Market Forecast (2015-2020) ($MN)
Table 61 Monoclonal Antibodies North America Market Forecast (2015-2020) ($MN)
Table 62 Vaccines North America Market Forecast (2015-2020) ($MN)
Table 63 Synthetic chemical API North America Market Forecast (2015-2020) ($MN)
Table 64 Generic Synthetic API North America Market Forecast (2015-2020) ($MN)
Table 65 Innovative Synthetic API North America Market Forecast (2015-2020) ($MN)
Table 66 Active Pharmaceutical Ingredients market by type of manufacturing North America Market Forecast (2015-2020) ($MN)
Table 67 API contract manufacturing North America Market Forecast (2015-2020) ($MN)
Table 68 Captive API Manufacturers North America Market Forecast (2015-2020) ($MN)
Table 69 Active Pharmaceutical Ingredients market by Type of Drug North America Market Forecast (2015-2020) ($MN)
Table 70 Generic Prescription Drugs North America Market Forecast (2015-2020) ($MN)
Table 71 Over-the-counter Drugs North America Market Forecast (2015-2020) ($MN)
Table 72 Branded Prescription Drugs North America Market Forecast (2015-2020) ($MN)
Table 73 Active Pharmaceutical Ingredients market by Therapeutic applications Europe Market Forecast (2015-2020) ($MN)
Table 74 Anti-Infectives Europe Market Forecast (2015-2020) ($MN)
Table 75 Cardiovascular and hematopoietic system Europe Market Forecast (2015-2020) ($MN)
Table 76 Diabetes Europe Market Forecast (2015-2020) ($MN)
Table 77 Endocrinology Europe Market Forecast (2015-2020) ($MN)
Table 78 Gastrointestinal disorder Europe Market Forecast (2015-2020) ($MN)
Table 79 Hormonal-related disorder Europe Market Forecast (2015-2020) ($MN)
Table 80 Metabolic disorder Europe Market Forecast (2015-2020) ($MN)
Table 81 Musculo-skeletal disorder Europe Market Forecast (2015-2020) ($MN)
Table 82 Nephrology Europe Market Forecast (2015-2020) ($MN)
Table 83 Neurological Disorders Europe Market Forecast (2015-2020) ($MN)
Table 84 Obesity Europe Market Forecast (2015-2020) ($MN)
Table 85 Oncology Europe Market Forecast (2015-2020) ($MN)
Table 86 Ophthalmology Europe Market Forecast (2015-2020) ($MN)
Table 87 Orthopedic Disorders Europe Market Forecast (2015-2020) ($MN)
Table 88 Pulmonology Europe Market Forecast (2015-2020) ($MN)
Table 89 Respiratory System Europe Market Forecast (2015-2020) ($MN)
Table 90 Others Europe Market Forecast (2015-2020) ($MN)
Table 91 ENT Europe Market Forecast (2015-2020) ($MN)
Table 92 Anesthesia Europe Market Forecast (2015-2020) ($MN)
Table 93 Eye Europe Market Forecast (2015-2020) ($MN)
Table 94 Active Pharmaceutical Ingredients market by type of API Europe Market Forecast (2015-2020) ($MN)
Table 95 Biotech API Europe Market Forecast (2015-2020) ($MN)
Table 96 Recombinant Proteins Europe Market Forecast (2015-2020) ($MN)
Table 97 Monoclonal Antibodies Europe Market Forecast (2015-2020) ($MN)
Table 98 Vaccines Europe Market Forecast (2015-2020) ($MN)
Table 99 Synthetic chemical API Europe Market Forecast (2015-2020) ($MN)
Table 100 Generic Synthetic API Europe Market Forecast (2015-2020) ($MN)
Table 101 Innovative Synthetic API Europe Market Forecast (2015-2020) ($MN)
Table 102 Active Pharmaceutical Ingredients market by type of manufacturing Europe Market Forecast (2015-2020) ($MN)
Table 103 API contract manufacturing Europe Market Forecast (2015-2020) ($MN)
Table 104 Captive API Manufacturers Europe Market Forecast (2015-2020) ($MN)
Table 105 Active Pharmaceutical Ingredients market by Type of Drug Europe Market Forecast (2015-2020) ($MN)
Table 106 Generic Prescription Drugs Europe Market Forecast (2015-2020) ($MN)
Table 107 Over-the-counter Drugs Europe Market Forecast (2015-2020) ($MN)
Table 108 Branded Prescription Drugs Europe Market Forecast (2015-2020) ($MN)
Table 109 Active Pharmaceutical Ingredients market by Therapeutic applications Asia Pacific Market Forecast (2015-2020) ($MN)
Table 110 Anti-Infectives Asia Pacific Market Forecast (2015-2020) ($MN)
Table 111 Cardiovascular and hematopoietic system Asia Pacific Market Forecast (2015-2020) ($MN)
Table 112 Diabetes Asia Pacific Market Forecast (2015-2020) ($MN)
Table 113 Endocrinology Asia Pacific Market Forecast (2015-2020) ($MN)
Table 114 Gastrointestinal disorder Asia Pacific Market Forecast (2015-2020) ($MN)
Table 115 Hormonal-related disorder Asia Pacific Market Forecast (2015-2020) ($MN)
Table 116 Metabolic disorder Asia Pacific Market Forecast (2015-2020) ($MN)
Table 117 Musculo-skeletal disorder Asia Pacific Market Forecast (2015-2020) ($MN)
Table 118 Nephrology Asia Pacific Market Forecast (2015-2020) ($MN)
Table 119 Neurological Disorders Asia Pacific Market Forecast (2015-2020) ($MN)
Table 120 Obesity Asia Pacific Market Forecast (2015-2020) ($MN)
Table 121 Oncology Asia Pacific Market Forecast (2015-2020) ($MN)
Table 122 Ophthalmology Asia Pacific Market Forecast (2015-2020) ($MN)
Table 123 Orthopedic Disorders Asia Pacific Market Forecast (2015-2020) ($MN)
Table 124 Pulmonology Asia Pacific Market Forecast (2015-2020) ($MN)
Table 125 Respiratory System Asia Pacific Market Forecast (2015-2020) ($MN)
Table 126 Others Asia Pacific Market Forecast (2015-2020) ($MN)
Table 127 ENT Asia Pacific Market Forecast (2015-2020) ($MN)
Table 128 Anesthesia Asia Pacific Market Forecast (2015-2020) ($MN)
Table 129 Eye Asia Pacific Market Forecast (2015-2020) ($MN)
Table 130 Active Pharmaceutical Ingredients market by type of API Asia Pacific Market Forecast (2015-2020) ($MN)
Table 131 Biotech API Asia Pacific Market Forecast (2015-2020) ($MN)
Table 132 Recombinant Proteins Asia Pacific Market Forecast (2015-2020) ($MN)
Table 133 Monoclonal Antibodies Asia Pacific Market Forecast (2015-2020) ($MN)
Table 134 Vaccines Asia Pacific Market Forecast (2015-2020) ($MN)
Table 135 Synthetic chemical API Asia Pacific Market Forecast (2015-2020) ($MN)
Table 136 Generic Synthetic API Asia Pacific Market Forecast (2015-2020) ($MN)
Table 137 Innovative Synthetic API Asia Pacific Market Forecast (2015-2020) ($MN)
Table 138 Active Pharmaceutical Ingredients market by type of manufacturing Asia Pacific Market Forecast (2015-2020) ($MN)
Table 139 API contract manufacturing Asia Pacific Market Forecast (2015-2020) ($MN)
Table 140 Captive API Manufacturers Asia Pacific Market Forecast (2015-2020) ($MN)
Table 141 Active Pharmaceutical Ingredients market by Type of Drug Asia Pacific Market Forecast (2015-2020) ($MN)
Table 142 Generic Prescription Drugs Asia Pacific Market Forecast (2015-2020) ($MN)
Table 143 Over-the-counter Drugs Asia Pacific Market Forecast (2015-2020) ($MN)
Table 144 Branded Prescription Drugs Asia Pacific Market Forecast (2015-2020) ($MN)
Table 145 Active Pharmaceutical Ingredients market by Therapeutic applications Middle East Market Forecast (2015-2020) ($MN)
Table 146 Anti-Infectives Middle East Market Forecast (2015-2020) ($MN)
Table 147 Cardiovascular and hematopoietic system Middle East Market Forecast (2015-2020) ($MN)
Table 148 Diabetes Middle East Market Forecast (2015-2020) ($MN)
Table 149 Endocrinology Middle East Market Forecast (2015-2020) ($MN)
Table 150 Gastrointestinal disorder Middle East Market Forecast (2015-2020) ($MN)
Table 151 Hormonal-related disorder Middle East Market Forecast (2015-2020) ($MN)
Table 152 Metabolic disorder Middle East Market Forecast (2015-2020) ($MN)
Table 153 Musculo-skeletal disorder Middle East Market Forecast (2015-2020) ($MN)
Table 154 Nephrology Middle East Market Forecast (2015-2020) ($MN)
Table 155 Neurological Disorders Middle East Market Forecast (2015-2020) ($MN)
Table 156 Obesity Middle East Market Forecast (2015-2020) ($MN)
Table 157 Oncology Middle East Market Forecast (2015-2020) ($MN)
Table 158 Ophthalmology Middle East Market Forecast (2015-2020) ($MN)
Table 159 Orthopedic Disorders Middle East Market Forecast (2015-2020) ($MN)
Table 160 Pulmonology Middle East Market Forecast (2015-2020) ($MN)
Table 161 Respiratory System Middle East Market Forecast (2015-2020) ($MN)
Table 162 Others Middle East Market Forecast (2015-2020) ($MN)
Table 163 ENT Middle East Market Forecast (2015-2020) ($MN)
Table 164 Anesthesia Middle East Market Forecast (2015-2020) ($MN)
Table 165 Eye Middle East Market Forecast (2015-2020) ($MN)
Table 166 Active Pharmaceutical Ingredients market by type of API Middle East Market Forecast (2015-2020) ($MN)
Table 167 Biotech API Middle East Market Forecast (2015-2020) ($MN)
Table 168 Recombinant Proteins Middle East Market Forecast (2015-2020) ($MN)
Table 169 Monoclonal Antibodies Middle East Market Forecast (2015-2020) ($MN)
Table 170 Vaccines Middle East Market Forecast (2015-2020) ($MN)
Table 171 Synthetic chemical API Middle East Market Forecast (2015-2020) ($MN)
Table 172 Generic Synthetic API Middle East Market Forecast (2015-2020) ($MN)
Table 173 Innovative Synthetic API Middle East Market Forecast (2015-2020) ($MN)
Table 174 Active Pharmaceutical Ingredients market by type of manufacturing Middle East Market Forecast (2015-2020) ($MN)
Table 175 API contract manufacturing Middle East Market Forecast (2015-2020) ($MN)
Table 176 Captive API Manufacturers Middle East Market Forecast (2015-2020) ($MN)
Table 177 Active Pharmaceutical Ingredients market by Type of Drug Middle East Market Forecast (2015-2020) ($MN)
Table 178 Generic Prescription Drugs Middle East Market Forecast (2015-2020) ($MN)
Table 179 Over-the-counter Drugs Middle East Market Forecast (2015-2020) ($MN)
Table 180 Branded Prescription Drugs Middle East Market Forecast (2015-2020) ($MN)
Table 181 Active Pharmaceutical Ingredients market by Therapeutic applications Latin America Market Forecast (2015-2020) ($MN)
Table 182 Anti-Infectives Latin America Market Forecast (2015-2020) ($MN)
Table 183 Cardiovascular and hematopoietic system Latin America Market Forecast (2015-2020) ($MN)
Table 184 Diabetes Latin America Market Forecast (2015-2020) ($MN)
Table 185 Endocrinology Latin America Market Forecast (2015-2020) ($MN)
Table 186 Gastrointestinal disorder Latin America Market Forecast (2015-2020) ($MN)
Table 187 Hormonal-related disorder Latin America Market Forecast (2015-2020) ($MN)
Table 188 Metabolic disorder Latin America Market Forecast (2015-2020) ($MN)
Table 189 Musculo-skeletal disorder Latin America Market Forecast (2015-2020) ($MN)
Table 190 Nephrology Latin America Market Forecast (2015-2020) ($MN)
Table 191 Neurological Disorders Latin America Market Forecast (2015-2020) ($MN)
Table 192 Obesity Latin America Market Forecast (2015-2020) ($MN)
Table 193 Oncology Latin America Market Forecast (2015-2020) ($MN)
Table 194 Ophthalmology Latin America Market Forecast (2015-2020) ($MN)
Table 195 Orthopedic Disorders Latin America Market Forecast (2015-2020) ($MN)
Table 196 Pulmonology Latin America Market Forecast (2015-2020) ($MN)
Table 197 Respiratory System Latin America Market Forecast (2015-2020) ($MN)
Table 198 Others Latin America Market Forecast (2015-2020) ($MN)
Table 199 ENT Latin America Market Forecast (2015-2020) ($MN)
Table 200 Anesthesia Latin America Market Forecast (2015-2020) ($MN)
Table 201 Eye Latin America Market Forecast (2015-2020) ($MN)
Table 202 Active Pharmaceutical Ingredients market by type of API Latin America Market Forecast (2015-2020) ($MN)
Table 203 Biotech API Latin America Market Forecast (2015-2020) ($MN)
Table 204 Recombinant Proteins Latin America Market Forecast (2015-2020) ($MN)
Table 205 Monoclonal Antibodies Latin America Market Forecast (2015-2020) ($MN)
Table 206 Vaccines Latin America Market Forecast (2015-2020) ($MN)
Table 207 Synthetic chemical API Latin America Market Forecast (2015-2020) ($MN)
Table 208 Generic Synthetic API Latin America Market Forecast (2015-2020) ($MN)
Table 209 Innovative Synthetic API Latin America Market Forecast (2015-2020) ($MN)
Table 210 Active Pharmaceutical Ingredients market by type of manufacturing Latin America Market Forecast (2015-2020) ($MN)
Table 211 API contract manufacturing Latin America Market Forecast (2015-2020) ($MN)
Table 212 Captive API Manufacturers Latin America Market Forecast (2015-2020) ($MN)
Table 213 Active Pharmaceutical Ingredients market by Type of Drug Latin America Market Forecast (2015-2020) ($MN)
Table 214 Generic Prescription Drugs Latin America Market Forecast (2015-2020) ($MN)
Table 215 Over-the-counter Drugs Latin America Market Forecast (2015-2020) ($MN)
Table 216 Branded Prescription Drugs Latin America Market Forecast (2015-2020) ($MN)
Table 217 Active Pharmaceutical Ingredients market by Therapeutic applications RoW Market Forecast (2015-2020) ($MN)
Table 218 Anti-Infectives RoW Market Forecast (2015-2020) ($MN)
Table 219 Cardiovascular and hematopoietic system RoW Market Forecast (2015-2020) ($MN)
Table 220 Diabetes RoW Market Forecast (2015-2020) ($MN)
Table 221 Endocrinology RoW Market Forecast (2015-2020) ($MN)
Table 222 Gastrointestinal disorder RoW Market Forecast (2015-2020) ($MN)
Table 223 Hormonal-related disorder RoW Market Forecast (2015-2020) ($MN)
Table 224 Metabolic disorder RoW Market Forecast (2015-2020) ($MN)
Table 225 Musculo-skeletal disorder RoW Market Forecast (2015-2020) ($MN)
Table 226 Nephrology RoW Market Forecast (2015-2020) ($MN)
Table 227 Neurological Disorders RoW Market Forecast (2015-2020) ($MN)
Table 228 Obesity RoW Market Forecast (2015-2020) ($MN)
Table 229 Oncology RoW Market Forecast (2015-2020) ($MN)
Table 230 Ophthalmology RoW Market Forecast (2015-2020) ($MN)
Table 231 Orthopedic Disorders RoW Market Forecast (2015-2020) ($MN)
Table 232 Pulmonology RoW Market Forecast (2015-2020) ($MN)
Table 233 Respiratory System RoW Market Forecast (2015-2020) ($MN)
Table 234 Others RoW Market Forecast (2015-2020) ($MN)
Table 235 ENT RoW Market Forecast (2015-2020) ($MN)
Table 236 Anesthesia RoW Market Forecast (2015-2020) ($MN)
Table 237 Eye RoW Market Forecast (2015-2020) ($MN)
Table 238 Active Pharmaceutical Ingredients market by type of API RoW Market Forecast (2015-2020) ($MN)
Table 239 Biotech API RoW Market Forecast (2015-2020) ($MN)
Table 240 Recombinant Proteins RoW Market Forecast (2015-2020) ($MN)
Table 241 Monoclonal Antibodies RoW Market Forecast (2015-2020) ($MN)
Table 242 Vaccines RoW Market Forecast (2015-2020) ($MN)
Table 243 Synthetic chemical API RoW Market Forecast (2015-2020) ($MN)
Table 244 Generic Synthetic API RoW Market Forecast (2015-2020) ($MN)
Table 245 Innovative Synthetic API RoW Market Forecast (2015-2020) ($MN)
Table 246 Active Pharmaceutical Ingredients market by type of manufacturing RoW Market Forecast (2015-2020) ($MN)
Table 247 API contract manufacturing RoW Market Forecast (2015-2020) ($MN)
Table 248 Captive API Manufacturers RoW Market Forecast (2015-2020) ($MN)
Table 249 Active Pharmaceutical Ingredients market by Type of Drug RoW Market Forecast (2015-2020) ($MN)
Table 250 Generic Prescription Drugs RoW Market Forecast (2015-2020) ($MN)
Table 251 Over-the-counter Drugs RoW Market Forecast (2015-2020) ($MN)
Table 252 Branded Prescription Drugs RoW Market Forecast (2015-2020) ($MN)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.